Karl Anders Olof Härfstrand is a businessperson who founded Härfstrand Consulting AG and who has been at the helm of 8 different companies.
He occupies the position of Chairman at Oasmia Pharmaceutical AB and Chairman at Härfstrand Consulting AG.
He is also on the board of Prothena Corp. Plc.
In his past career he held the position of President & Chief Executive Officer of ADAMA Agriculture BV, Chief Executive Officer for to-BBB Holding BV, Chief Executive Officer for to-BBB technologies BV, Principal at Pharmacia, Inc., Senior Executive Vice President at Serono International SA, President & Chief Executive Officer at ADAMA Agricultural Solutions Ltd., Chief Executive Officer & Director at Horizon Therapeutics Schweiz GmbH, President & Chief Executive Officer of Humabs BioMed SA, Vice President-Country Operations at Pharmacia & Upjohn, Inc., Vice President-Country Operations at Pharmacia AB, Senior Executive Vice President at EMD Serono, Inc. and Director & Executive Vice President at Pfizer Japan, Inc.
Karl Anders Olof Härfstrand received a doctorate from Karolinska Institutet.